Physician
Pathology
Dr. Christine A. Haller, MD
|
|
Give Review
Christine Haller is an expert in the field of Pathology. She studied medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a top medical college. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. Christine A. Haller has written publications. She has 42 publications published with PubMed. The lastest publication is: 'Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle.'
Publications
- Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial.
- Multi-domain impact of elosufase alfa in Morquio A syndrome in the pivotal phase III trial.
- Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia(®) (denosumab) for the treatment of postmenopausal osteoporosis.
- Practical approaches to dose selection for first-in-human clinical trials with novel biopharmaceuticals.
- Prevalence of smoking assessed biochemically in an urban public hospital: a rationale for routine cotinine screening.
- Gamma-hydroxybutyrate and ethanol effects and interactions in humans.
- Incomplete recovery of prescription opioids in urine using enzymatic hydrolysis of glucuronide metabolites.
- Comparison of an automated and point-of-care immunoassay to GC-MS for urine oxycodone testing in the clinical laboratory.
- Clinical approach to adverse events and interactions related to herbal and dietary supplements.
- Hemodynamic effects of ephedra-free weight-loss supplements in humans.
- Short-term metabolic and hemodynamic effects of ephedra and guarana combinations.
- Seizures reported in association with use of dietary supplements.
- St John's wort, depression, and catecholamines.
- Enhanced stimulant and metabolic effects of combined ephedrine and caffeine.
- Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements.
- Determination of ephedra alkaloid and caffeine concentrations in dietary supplements and biological fluids.
- Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers.
- Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use.
- Making a diagnosis of herbal-related toxic hepatitis.
- Effect of gamma-hydroxybutyrate on local and global glucose metabolism in the anesthetized cat brain.
- Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle.
- Adverse drug reactions: moving from chance to science.
- Out of the medicine closet: time to talk straight about prescription drug abuse.
- Immobilization-induced hypercalcemia in a renal transplant recipient with persistent hyperparathyroidism.
- Central nervous system depression after ingestion of RenewTrient.
- Nutraceuticals: has there been any progress?
- More bad news about anti-inflammatory agents.
- Pharmacologic agents for weight reduction.
- We should always ask our patients about unconventional treatments.
- Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases.
- Adverse events associated with dietary supplements: an observational study.
- Safety issues specific to clinical development of protein therapeutics.
- Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.
- Photosensitivity reaction in a woman using an herbal supplement containing ginseng, goldenseal, and bee pollen.
- Dietary supplement adverse events: report of a one-year poison center surveillance project.
- Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
- Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects.
- GHB urine concentrations after single-dose administration in humans.
- Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers.
- An evaluation of selected herbal reference texts and comparison to published reports of adverse herbal events.
- Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions.
Schools
University of California At San Francisco
Doctors Specialties
- Medical Toxicology
- Pathology
Accepted Insurances
Education
-
UCSF -
University of California San Francisco School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Abul K. Abbas, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Lynn D. Bui, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kimberley J. Evason, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul D. Blanc, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Ryan M. Gill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew W. Bollen, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Scott A. Oakes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodore W. Kurtz, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Roderick G. Snow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig G. Smollin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lada B. Kokan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonee M. Taylor, MD |
|
|
Dr. Zhen Yan, MD
This Doctor is OpenDoctor Recommended.
|